Stay updated with the latest recombinant-dna news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on recombinant-dna topics.

Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses). The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple admini ...Read More >

New Delhi [India], August 22 (ANI): India drug regulator has alerted on the theft of multiple drug products of Novo Nordisk during transit. According to the notice issued by the Drugs Controller General of India (DCGI), Dr Rajeev Raghuvanshi, Mis Novo Nordisk has informed about a theft of its products, as mentioned below, during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata). The DCGI has also mentioned in the notice that the quality of the injectables is re ...Read More >

New Delhi, Aug 12 (PTI) Drug firm Lupin on Tuesday said it has partnered with Switzerland-based Sandoz Group AG to commercialise its biosimilar ranibizumab across multiple regions. Under the terms of the agreement, Sandoz will oversee commercialisation of the product across the European Union (excluding Germany), Switzerland, Norway, Australia, Hong Kong, Vietnam, and Malaysia, the Mumbai-based drug maker said in a statement. Lupin will be responsible for manufacturing the product and for regu ...Read More >

New Delhi, Jul 20 (PTI) Star Indian long jumper Murali Sreeshankar clinched the title with a leap of 7.75m at the Meeting Maia Cidade do Desporto in Maia, Portugal, a World Athletics Continental Tour Bronze-level meet. The Asian Games silver medallist registered his best effort in the second round on Saturday night. Sreeshankar opened with a 7.63m jump, followed it up with his winning leap of 7.75m in the second round, and then recorded a solid 7.69m. His third attempt was a foul, while his fi ...Read More >

New Delhi [India], July 20 (ANI): The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax. AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target tw ...Read More >
New Delhi [India], July 20 (ANI): The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax. AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target tw ...Read More >
Bhubaneswar: The Indian Council of Medical Research (ICMR), New Delhi, on Thursday invited expressions of interest from eligible organisations, companies, and manufacturers for undertaking the 'transfer of technology' for commercialisation of a malaria vaccine developed by ICMR-Regional Medical Research Centre (RMRC), Bhubaneswar.This technology, "A recombinant chimeric multi-stage malaria vaccine (AdFalciVax) against Plasmodium falciparum", is useful in preventing Plasmodium falciparum infectio ...Read More >

New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >

New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >

New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage ...Read More >

Dr. Mujahid Gilani (Senior Kashmiri Leader): Long before 14 August 1947, people of Jammu and Kashmir had voted in favour of Pakistan even before the division of Sub-Continent. They gave their decision over vehemently to become to join Pakistan as its Muslim majority province. In the backdrop of global situation, we must realize that people of Jammu and Kashmir are struggling for maintaining their lives. Their ratio of population in Jammu and Kashmir which was over 98 % in 1947 has been reduced a ...Read More >

Hyderabad (Telangana) [India], July 1 (ANI): Jiangsu Recbio Technology Company Limited (02179.HK), announced that they have entered into a licensing cooperation agreement, and have commenced the technology transfer of their Recombinant 9-valent HPV (HPV9) vaccine, REC603, to Biological E. Limited (BE), a leading Indian vaccine and pharmaceutical company. Recbio will provide BE with Drug Substance (DS) and transfer technology to formulate, fill, and package vaccines. It will also include technolo ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.